The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit...

March for Science, Why I March

John (PharmaGuy) Mack speaking at the March for Science in Doylestown, PA. My name is John Mack and I live in Newtown. On Twitter I am known as PharmaGuy – that’s P-H-A-R-M-A, plus “Guy!” I PUBLISH...

Speedy Drug Approval Versus Safe Drugs: Can We Have Both?

More user fees paid to the FDA by the drug industry and the push for less rigorous scientific proof in clinical trials may lead to faster drug approvals, but also more...

Making Sense of DTC Ad Spending

About this time every year, I get data from Kantar Media and Nielsen regarding how much money the U.S. pharmaceutical industry spends on direct-to-consumer (DTC) advertising. The data I’m most interested in...

A Drug By Any Other Name

The naming of drugs has been described both as a science and an art, which is also true about marketing in general. No matter what side of the brain is involved, there...

PharmaGuy To Compete for Recognition at Cannes Lion Health Festival

April 1, 2017: PharmaGuy is excited to announce that the organizers of the 2017 Cannes Lion Health Festival have chosen him as one of the finalists to compete for this year’s...

Which is Bigger: Pharma Profits or R&D Spending?

On Mar 27, 2017, Public Citizen came out with a report that claimed "Pharmaceutical Industry Profits Are Nearly Double R&D Costs in 2013, 2014 and 2015". The email announcing the report...

The Context Problem Foils Pharma Online Advertising

Click on image to enlarge. Last week I came across an article about Johnson & Johnson and other pharma companies pulling their ads from Youtube because they appeared adjacent to hate speech,...

How Many Adverse Event Reports Are Submitted to the FDA? Whatever the Answer, It’s...

I've been tracking the number of adverse event reports (AERs) submitted to the FDA over the years based on data supplied by the FDA here. The latest update of that data...

Gottlieb to Head FDA: Pharma Breathes a Sigh of Relief

Trump Chooses Scott Gottlieb to Head FDA; Pharma Breathes Sigh of Relief

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -